Sigma_Labs

Sigma Labs Continues to Disappoint Investors

Our readers know how we feel about over the counter (OTC) companies. Countless OTC companies have lost investors' money over the years and while there may be the rare exception, you won't find the next Microsoft on the OTC exchange. We will continue to call out companies that are long on promises and press releases and short on delivery and you'll never find us on the long or short side of any OTC company. Take Sigma Labs (OTCMKTS:SGLB) for instance. Since our first article in July of 2013, SGLB has seen some volatile trading with shares up +23% since our first article. In November of 2013, the shares would have been up +400% and just last month down -16%. Speculators may have made some money through this volatile trading but investors are left scratching their heads after last week's 2014 yearly financials. Let's take a look why. In fiscal 2014, B6 Sigma along with Sumner Associates generated an aggregate [...]

Savo_Solar_Teaser

Investing in Solar Collectors with Savo Solar

The amount of energy contained within the sun is incredibly large. At any given time the earth receives 174 Trillion kilowatts of energy from the sun which is 6,000 times our worldwide energy usage. The below chart puts this into perspective: There is more energy shed from the sun than any other energy source and far more than we would ever need. Traditionally we think about harvesting energy from the sun through solar cells which continue to grow more efficient and become more economically viable as each day passes. However solar cells are not the only way to harvest the energy from our star. Solar startup Brightsource uses mirrors to reflect sunlight and capture energy heating a boiler that creates steam. Then there is the concept of a solar thermal collector which in a similar fashion, uses panels to absorb the radiation of the sun to create heat. The heat can then be transferred to various mediums such as [...]

OpGen_Teaser

TINY: OpGen Files for IPO

We've written a fair number of articles before about disruptive technology venture capital fund Harris and Harris Group (NASDAQ:TINY). While the fund itself hasn't treated investors very well over time, some of their holdings such as D-Wave do seem to have lucrative potential. One TINY holding which filed for an IPO this past week is OpGen.     MDROs: The Problem to Solve  While antibiotics can be an effective treatment for many ailments, multi-drug-resistant organisms, or MDROs are bacteria that have become resistant to certain antibiotics, and these antibiotics can no longer be used to control or kill the bacteria. MDROs are found mainly in hospitals and long-term care facilities. The CDC estimates that in the United States more than two million people are sickened every year with antibiotic-resistant infections, with at least 23,000 dying as a result. Estimates for the total economic cost [...]

D-Wave_Teaser

Investing in Quantum Computing with TINY and D-Wave

We've talked before about disruptive technology venture capital fund Harris and Harris Group (NASDAQ:TINY) and their dismal share price performance over time. We've also highlighted that any single successful exit for one of TINY's larger investments could be quite beneficial for TINY's shareholders. Let's take a look at an investment by Harris and Harris Group in D-Wave, a Canadian quantum computing company that has the potential to be truly disruptive. Why Quantum Computing? Quantum computing has always been thought of as the holy grail for technologists. Just why is this the case? Well the simple explanation requires a bit of background. In computing, there is a rule we call Moore's law which states that "computer chip performance doubles every 2 years". Silicon chips, which are the foundation of computing today, will eventually reach their technological limit. Quantum computing promises a solution that would [...]

OpGen_Teaser

TINY: OpGen Files for IPO

We've written a fair number of articles before about disruptive technology venture capital fund Harris and Harris Group (NASDAQ:TINY). While the fund itself hasn't treated investors very well over time, some of their holdings such as D-Wave do seem to have lucrative potential. One TINY holding which filed for an IPO this past week is OpGen.     MDROs: The Problem to Solve  While antibiotics can be an effective treatment for many ailments, multi-drug-resistant organisms, or MDROs are bacteria that have become resistant to certain antibiotics, and these antibiotics can no longer be used to control or kill the bacteria. MDROs are found mainly in hospitals and long-term care facilities. The CDC estimates that in the United States more than two million people are sickened every year with antibiotic-resistant infections, with at least 23,000 dying as a result. Estimates for the total economic cost [...]

Lastest Articles

OpGen_Teaser

TINY: OpGen Files for IPO

We've written a fair number of articles before about disruptive technology venture capital fund Harris and Harris Group (NASDAQ:TINY). While the fund itself hasn't treated investors very well over time, some of their holdings such as D-Wave do seem to have lucrative [...]

Sigma_Labs

Sigma Labs Continues to Disappoint Investors

Our readers know how we feel about over the counter (OTC) companies. Countless OTC companies have lost investors' money over the years and while there may be the rare exception, you won't find the next Microsoft on the OTC exchange. We will continue to call out companies [...]

Nanoco_Teaser

Nanoco’s First Quantum Dot Televisions

Quantum dots are tiny bits of semiconductor crystals that are less than 10 nanometers in size. These nanomaterials exhibit remarkable properties that open up a broad array of applications such as biological tagging, LEDs, displays, and even solar cells. Nanoco [...]

NANTHEALTH_Teaser

Will a NantHealth IPO Happen in 2015?

        In a June 2014 article we highlighted a company called NantHealth, led by Patrick Soon-Shiong who is the wealthiest American in the healthcare industry having amassed a fortune of $7.2 billion for building and selling  Abraxis [...]